Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Consensus paper of the WF… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

Forskningsöversiktsartikel
Författare J Wiltfang
P Lewczuk
P Riederer
E Grünblatt
C Hock
P Scheltens
H Hampel
H Vanderstichele
K Iqbal
D Galasko
L Lannfelt
M Otto
H Esselmann
A W Henkel
J Kornhuber
Kaj Blennow
Publicerad i The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
Volym 6
Nummer/häfte 2
Sidor 69-84
ISSN 1562-2975
Publiceringsår 2005
Publicerad vid Institutionen för klinisk neurovetenskap, Sektionen för laborativ neurovetenskap
Sidor 69-84
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Aged, Alzheimer Disease, blood, cerebrospinal fluid, genetics, Amyloid beta-Protein Precursor, cerebrospinal fluid, Apolipoproteins E, genetics, Biological Markers, blood, cerebrospinal fluid, Consensus, Diagnosis, Differential, Genotype, Humans, Immunoblotting, Microtubule-Associated Proteins, metabolism, Neurons, metabolism, Phosphorylation, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Time Factors, tau Proteins, cerebrospinal fluid
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

Aging of population, and increasing life expectancy result in an increasing number of patients with dementia. This symptom can be a part of a completely curable disease of the central nervous system (e.g, neuroinflammation), or a disease currently considered irreversible (e.g, Alzheimer's disease, AD). In the latter case, several potentially successful treatment approaches are being tested now, demanding reasonable standards of pre-mortem diagnosis. Cerebrospinal fluid and serum analysis (CSF/serum analysis), whereas routinely performed in neuroinflammatory diseases, still requires standardization to be used as an aid to the clinically based diagnosis of AD. Several AD-related CSF parameters (total tau, phosphorylated forms of tau, Abeta peptides, ApoE genotype, p97, etc.) tested separately or in a combination provide sensitivity and specificity in the range of 85%, the figure commonly expected from a good diagnostic tool. In this review, recently published reports regarding progress in neurochemical pre-mortem diagnosis of dementias are discussed with a focus on an early and differential diagnosis of AD. Novel perspectives offered by recently introduced technologies, e.g, fluorescence correlation spectroscopy (FCS) and surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) are briefly discussed.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?